JANSSEN PHARMACEUTICALS, INC. et al v. MYLAN LABORATORIES LIMITED > Summary
Court Case Number 3:21-cv-15137
Filing Date Aug 11, 2021
Termination Date Jan 7, 2022
Court New Jersey District Court
Status Dismissed - Other
JudgesZahid N. Quraishi, Lois H. Goodman
Defendant
Plaintiff Attorneys
13Janssen Research & Development
Attorney Name: Keith J. Miller
Robinson Miller
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Jay Joong Youn Cho
Patterson Belknap Webb & Tyler
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Aron R. Fischer
Patterson Belknap Webb & Tyler
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Robert Quirk
Patterson Belknap Webb & Tyler
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Andrew D. Cohen
Patterson Belknap Webb & Tyler
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Joyce L. Nadipuram
Patterson Belknap Webb & Tyler
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Barbara L. Mullin
Patterson Belknap Webb & Tyler
JANSSEN PHARMACEUTICALS (Johnson & Johnson)
Attorney Name: Lachlan Campbell-Verduyn
Patterson Belknap Webb & Tyler
Attorney Name: Andrew D. Cohen
Attorney Name: Jay Joong Youn Cho
Attorney Name: Andrew D. Cohen
Attorney Name: Jay Joong Youn Cho
Defendant Attorneys
7Viatris Inc.
Attorney Name: Arnold B. Calmann
Saiber
Viatris Inc.
Attorney Name: Katherine A. Escanlar
Saiber
Viatris Inc.
Attorney Name: Jeffrey Soos
Saiber
Viatris Inc.
Attorney Name: Jitendra Malik
Katten Muchin Rosenman
Viatris Inc.
Attorney Name: Jillian M. Schurr
Katten Muchin Rosenman
Viatris Inc.
Attorney Name: Deepro R. Mukerjee
Katten Muchin Rosenman
Viatris Inc.
Attorney Name: Lance A. Soderstrom
Katten Muchin Rosenman
Counter Defendant
2Janssen Research & Development
Attorney Name: Keith J. Miller
Robinson Miller
Counter Claimant
3Viatris Inc.
Attorney Name: Arnold B. Calmann
Saiber
Viatris Inc.
Attorney Name: Katherine A. Escanlar
Saiber
Viatris Inc.
Attorney Name: Jeffrey Soos
Saiber
Cause
15:1126 Patent Infringement
Related Patents
Doc No | Title | Issue date |
---|---|---|
10143693 | Dosing regimen for missed doses for long-acting injectable paliperidone esters | Dec 4, 2018 |